BioSpace News Archive

Business

Professor Charlotte Deane Joins Exscientia as Chief Scientist of Biologics AI

Professor Charlotte Deane, Ph.D., of the University of Oxford, has joined Exscientia as Chief Scientist of Biologics AI.

January 19, 2022
·
4 min read
Business

PLx Pharma Inc. Appoints Janet Barth to Newly Created Role of Vice President, Investor Relations & Corporate Communications

PLx Pharma Inc., is a commercial-stage drug delivery platform technology company focused on its clinically-validated and patent-protected PLxGuard™ that has the potential to improve the absorption of many drugs currently on the market and to reduce the risk of stomach injury associated with certain drugs.

January 19, 2022
·
3 min read
Deals

Eluminex Biosciences Acquires Zuretinol Acetate from Retinagenix Holdings

Eluminex Biosciences announced today that it has acquired certain assets and the related global development and commercialization rights for a novel oral therapy, zuretinol acetate (zuretinol), from Retinagenix Holdings, LLC (Retinagenix).

January 19, 2022
·
8 min read
Business

BioXcel Therapeutics Appoints Matt Wiley Chief Commercial Officer

BioXcel Therapeutics, Inc. today announced the appointment of Matt Wiley as Senior Vice President and Chief Commercial Officer (CCO).

January 19, 2022
·
5 min read
Business

ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business Update

Fourth Quarter 2021 Preliminary Unaudited Total Revenues of Approximately $26 Million, the Highest Quarterly Revenue for the Company Since Inception.

January 19, 2022
·
11 min read
Drug Development

Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Study of LNK01001 in Patients with Ankylosing Spondylitis

Lynk Pharmaceuticals Co., Ltd. announced today that the first patient has been dosed with LNK01001 in its Phase II clinical trial targeting ankylosing spondylitis.

January 19, 2022
·
2 min read
Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Mass Testing

Seegene Inc., South Korea’s leading molecular diagnostics company, announced the upcoming launch of the Allplex™ SARS-CoV-2 Fast PCR Assay, which can deliver PCR results in just 60 minutes.

January 19, 2022
·
3 min read
Deals

Ginkgo Bioworks Announces Acquisition of Massachusetts COVID-19 Testing Provider Project Beacon COVID-19 LLC

Ginkgo Bioworks today announced the acquisition of Project Beacon COVID-19 LLC (Project Beacon), a Boston-based social benefit organization focused on helping to increase the capacity, availability, accessibility and affordability of COVID-19 testing.

January 19, 2022
·
6 min read
Policy

FDA Accepts for Review Libtayo® (cemiplimab-rwlc) in Combination with Chemotherapy for First-line Treatment of Advanced NSCLC

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) for PD-1 inhibitor Libtayo.

January 19, 2022
·
17 min read
Business

Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer

Pharmaceutical leader brings over two decades of drug discovery and development in immunology and oncology.

January 19, 2022
·
3 min read